Search This Blog

Monday, December 31, 2018

Amarin (AMRN) Given a $35.00 Price Target at Cantor Fitzgerald


Amarin (NASDAQ:AMRN) has been given a $35.00 target price by research analysts at Cantor Fitzgerald in a report issued on Friday. The firm currently has a “buy” rating on the biopharmaceutical company’s stock.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)